NO20084140L - DNA-sekvens, RAP-2 bindende protein, isoform, fragment eller analog derav samt anvendelse derav og fremgangsmate for isolering og identifisering av proteiner som kan bli bundet til RAP-2. - Google Patents

DNA-sekvens, RAP-2 bindende protein, isoform, fragment eller analog derav samt anvendelse derav og fremgangsmate for isolering og identifisering av proteiner som kan bli bundet til RAP-2.

Info

Publication number
NO20084140L
NO20084140L NO20084140A NO20084140A NO20084140L NO 20084140 L NO20084140 L NO 20084140L NO 20084140 A NO20084140 A NO 20084140A NO 20084140 A NO20084140 A NO 20084140A NO 20084140 L NO20084140 L NO 20084140L
Authority
NO
Norway
Prior art keywords
rap
isoform
analogue
isolating
fragment
Prior art date
Application number
NO20084140A
Other languages
English (en)
Norwegian (no)
Inventor
David Wallach
Andrei Kovalenko
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL12375898A external-priority patent/IL123758A0/xx
Priority claimed from IL12602498A external-priority patent/IL126024A0/xx
Publication of NO20084140L publication Critical patent/NO20084140L/no
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Plant Pathology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20084140A 1998-03-19 2008-10-01 DNA-sekvens, RAP-2 bindende protein, isoform, fragment eller analog derav samt anvendelse derav og fremgangsmate for isolering og identifisering av proteiner som kan bli bundet til RAP-2. NO20084140L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL12375898A IL123758A0 (en) 1998-03-19 1998-03-19 Modulators of the function of receptors of the TNF/NGF receptor family and other proteins
IL12602498A IL126024A0 (en) 1998-03-19 1998-09-01 Modulators of the function of receptors of the tnf/ngf receptor family and other proteins
PCT/IL1999/000158 WO1999047672A1 (fr) 1998-03-19 1999-03-18 Modulateurs de la fonction de recepteurs de la famille des recepteurs tnf/ngf et d'autres proteines

Publications (1)

Publication Number Publication Date
NO20084140L true NO20084140L (no) 2000-10-30

Family

ID=40020126

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084140A NO20084140L (no) 1998-03-19 2008-10-01 DNA-sekvens, RAP-2 bindende protein, isoform, fragment eller analog derav samt anvendelse derav og fremgangsmate for isolering og identifisering av proteiner som kan bli bundet til RAP-2.

Country Status (9)

Country Link
US (1) US20040219615A1 (fr)
EP (1) EP1454985A3 (fr)
JP (1) JP2009148285A (fr)
KR (1) KR100693677B1 (fr)
AR (1) AR015247A1 (fr)
EE (1) EE200900055A (fr)
NO (1) NO20084140L (fr)
PL (1) PL199214B1 (fr)
SG (1) SG148025A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7521534B1 (en) * 2003-03-03 2009-04-21 The University Board Of Regents Of Texas System IKK gamma gene products and methods for making and using same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3860608B2 (ja) * 1995-02-22 2006-12-20 イエダ リサーチ アンド ディベロップメント カンパニー リミテッド 調節タンパク質のモジュレーター
US5674734A (en) * 1995-05-18 1997-10-07 President And Fellows Of Harvard College Cell death protein

Also Published As

Publication number Publication date
JP2009148285A (ja) 2009-07-09
AR015247A1 (es) 2001-04-18
SG148025A1 (en) 2008-12-31
EP1454985A2 (fr) 2004-09-08
EP1454985A3 (fr) 2004-12-01
KR20010034563A (ko) 2001-04-25
KR100693677B1 (ko) 2007-03-09
PL199214B1 (pl) 2008-08-29
EE200900055A (et) 2009-10-15
US20040219615A1 (en) 2004-11-04

Similar Documents

Publication Publication Date Title
ATE451390T1 (de) Polypeptide zur bindung an das b-lymphozyten- stimulatorische protein (blys)
NO20014584L (no) Proteinisolering og -analyse
DE69739105D1 (de) Survivin, ein protein das zelluläre apoptosis hemmt, und dessen modulation
DE69822307D1 (de) Menschliches adamts-1 protein, gen , welches für dieses kodiert, pharmazeutische zusammensetzung und verfahrem zur immunologischen bestimmung von menschlichen adamts-1 proteinen
EE200000151A (et) Aminoterminaalselt kärbitud rantes vormid, DNA molekulid, ekspressioonivektor, peremeesrakk, rekombinantne meetod proteiini valmistamiseks, proteiini kasutamine ning farmatseutiline kompositsioon
BRPI0512798A (pt) molécula de ácido nucleico recombinante, célula, método para produzir uma proteìna de interesse, uso de uma seqüência de ácido nucleico tendo atividade anti-repressora, métodos para gerar uma célula hospedeira expressando dois polipeptìdios de interesse, e para expressar dois polipeptìdios de interesse
DE69819124D1 (de) Lyophilisation von kultivierten, menschlichen zellen zur konservierung der rna und dna
DK0572688T3 (da) Peptider, med organ-beskyttende aktivitet, fremgangsmåde til deres fremstilling og deres anvendelse ved terapi
AU6745287A (en) Dna sequences coding for proteins having the biological activity of husi-type i inhibitors, biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins
DE69827284D1 (de) Funktionelle fragmente des hiv-1 vpr proteins and eine methode zu seiner anwendung
WO2002048403A3 (fr) Bioanalyse d'expression et d'activite de proteines multiples
DK1082423T3 (da) Cyclin E2-gener og -proteiner
NO20084140L (no) DNA-sekvens, RAP-2 bindende protein, isoform, fragment eller analog derav samt anvendelse derav og fremgangsmate for isolering og identifisering av proteiner som kan bli bundet til RAP-2.
ATE306666T1 (de) Verfahren zur eiweissanalyse
ATE414906T1 (de) Verfahren zur identifizierung von an das chaperonin cct bindenden substanzen
BG104769A (en) Modulators of the function of receptors of the tnf/ngf receptor family and other proteins
BR0211130A (pt) Plantas transgênicas que expressam proteìnas de ligação da cobalamina
ATE424453T1 (de) Mannosyl(1-2)glycosyl(1-2)glycerat zur stabilisierung und konservierung von biomaterialien
WO2004047758A3 (fr) Methodes therapeutiques et diagnostiques mettant en application le ciblage de cellules exprimant p2y10
WO2004005318A3 (fr) Peptides comprenant des aminoacides d aromatiques et leurs methodes d'utilisation
NO20002832D0 (no) Humantyroidprotein ZSig45 og DNA som koder for dette
AU2003215179A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and used thereof
AU4624997A (en) Nematode proteins, dna sequences coding therefor, their specific antibodies and their use in identifying nematicidal active substances
DE60128252D1 (de) Membranfraktionen von mit 1,2-sn-Diacylglycerol angereicherten Zellen
AR012938A1 (es) Metodo para producir una proteina codificada por una secuencia de adn, anticuerpo especifico para el polipeptido, metodo para aislar e identificar el polipeptido, metodo para rastrear e identificar ligandos.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application